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Abstract—Cardiovascular diseases are one of the leading
causes of death in most developed countries and aging is a
dominant risk factor for their development. Among the different
factors, miRNAs have been identified as relevant players in the
development of cardiac pathologies and their ability to influence
gene networks suggests them as potential therapeutic targets or
diagnostic markers. This paper presents a computational study
that applies data fusion techniques coupled with network analysis
theory to identify a regulatory model able to represent the
relationship between key genes and miRNAs involved in cardiac
senescence processes. The model has been validated through an
extensive literature analysis that was able to connect 94% of
the identified genes and miRNAs with cardiac senescence related
studies.
Index Terms—Senescence, heart, regulation, pathway, mi-
crorna.
I. INTRODUCTION
Aging affects several biological processes with a progressive
impairing of key physiological functions, reduced response to
stress and susceptibility to various diseases [1]. Cardiovascular
diseases are one of the leading causes of death in most
developed countries and aging is a dominant risk factor for
their development [2]. Identification of regulatory mechanisms
contributing to cardiac aging may help the identification of
early cardiovascular pathophysiological changes.
Different studies proposed potential causes for cardiac ag-
ing. These include decrease in telomerase activity and shorten-
ing of the DNA of the telomeres [3], increased oxidative stress
[4], loss of mitochondrial function [5] and impaired autophagy
[6]. Moreover, epigenetic regulators such as microRNAs (miR-
NAs) have been studied in several cellular aging processes
[7]. MiRNAs control the expression of genes involved in
several key biological processes such as cell development,
stem cell proliferation, division and differentiation, regulation
of immunity, apoptosis, cell signaling and metabolism. Aber-
rant expression of miRNAs has been associated with several
pathological processes [8]. MiRNAs substantially contribute
to the development of cardiac pathologies and their ability to
influence gene networks suggests them as potential therapeutic
targets or diagnostic markers [9], [10].
In this paper we propose a computational study that applies
data fusion techniques coupled with network analysis theory to
identify a regulatory model able to represent the relationship
between key genes and miRNAs involved in cardiac senes-
cence processes. This model represents a very preliminary
outcome that could help in the identification of molecular
mechanisms and pathways involving miRNAs responsible for
cardiac aging processes.
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II. MATERIALS AND METHODS
We developed a semi-automated pipeline able to identify
genes with key regulatory role in an aggregated multi-pathway
gene regulatory network (GRN). We started from a list of
differentially expressed genes related to cardiac aging, which
led to the identification of a subset of KEGG’s pathways. By
extending those pathways with their transcriptional and post-
transcriptional regulators we were able to compute gene cen-
trality measures across the pathways that eventually allowed us
to produce a list of high centrality nodes. Such nodes resulted
well interconnected, resembling a highly interconnected sub-
network able to dispatch key regulatory signals previously
associated with senescence [11]. Fig. 1 shows the overall data
flow that takes advantage of two Cytoscape plugins: (i) ReNE
[12], and, (ii) NetworkAnalyzer [13].
A. Data Selection
Two data sources were analyzed to identify the initial list
of candidate genes:
• a list of differentially expressed genes. Genes related
to cardiac aging in rat were extracted from GEO [14].
The selected experiment investigates effects of reduced
adrenergic signaling in the aged heart [15]1. Microarray
data were filtered using the GEO Differential Expression
filter. Furthermore, transcribed loci, pseudogenes, and
expressed sequence tags were removed from the obtained
list.
• a manually curated selection of pathways from KEGG
[16]. The whole list of KEGG pathways was ranked
according to the number of the previously identified genes
they contain. The top 15 ranked pathways were analyzed
performing a manual selection of interesting pathways.
B. Data Aggregation
The list of differentially expressed genes, and the selected
KEGG pathways were individually processed resorting to the
ReNE Cytoscape plugin [12]. The following operations were
performed using ReNE on each pathway:
• Naming normalization: since different databases use dif-
ferent ways to identify genetic entities all symbols were
converted according to their NCBI [17] and Uniprot [18]
unique identifiers, thus allowing to navigate across public
omic repositories without ambiguities.
1Data accessible at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE421,
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Figure 1. Green balloons identify Input/Intermediate/Output data; Cyan balloons identify processing activities. Pathways from KEGG and a list of differentially expressed genes
from GEO were processed in ReNE, producing a set of extended networks. The extended networks were analyzed with NetworkAnalyzer and R scripts to identify nodes with high
centrality score. The extended networks were merged obtaining an extended merged network modeling the whole set of regulations. Genes with high centrality (identified in the R
processing step) were used to filter the extended merged network producing a filtered subnetwork containing the most central nodes possibly involved in cardiac aging.
• Transcriptional enhancing: transcription factors (TFs) of
each gene were systematically retrieved from TargetMine
[19] and integrated in the analyzed networks creating new
TF nodes with outgoing edges directed to their target
genes.
• Post-transcriptional enhancing: intragenic miRNAs
hosted by the network genes were identified by ReNE
from the miRIAD database [20] and inserted in the
network. Intragenic miRNAs selected in this way are
known to be co-expressed with their host genes [21].
miRNAs are commonly not reported in publicly available
regulatory pathways. Nonetheless they act as regulatory
hubs that lead to complex post-transcriptional regulatory
motifs able to fine tuning genetic regulatory signaling
cascades. For each identified miRNA the list of its
targets was computed by ReNE by searching multiple
miRNA target databases using the TargetHUB services
[22], thus connecting miRNAs with their targets in the
pathways.
C. Data Processing
Network topology parameters were computed for each pro-
cessed network using the Cytoscape NetworkAnalyzer plugin
[13]. Among the large amount of scores produced by Net-
workAnalyzer, we selected the centrality measures since they
have been demonstrated particularly useful to identify key
players in biological processes [23], e.g., highly connected
vertices in protein interaction networks are often functionally
important and their deletion is often related to lethality [24].
NetworkAnalyzer provides two centrality measures: (i) close-
ness centrality, and (ii) betweenness centrality. The closeness
centrality uses information about the length of the shortest
paths within a network. However, since this distance is only
defined for pairwise strongly connected vertices, it can only
be used with strongly connected networks. On the other hand,
the betweenness centrality quantifies the ability of a vertex
to monitor the communication between other vertices. Every
vertex that is part of a shortest path between two vertices
can monitor the communication between them. Counting
how many communications a vertex can monitor provides
an intuitive definition of centrality: a vertex is central if it
can monitor several communications between other vertices.
[23]. Shortest-path betweenness centrality was applied to
mammalian transcriptional regulatory networks and it was
noted that betweenness appears to be an interesting topological
characteristic in regard to the biological significance of distinct
elements [25]. Betweenness centrality was therefore exploited
to identify genes whose role is central enough to possibly
induce misbehavior when ectopically expressed under aging
conditions.
NetworkAnalizer results were processed with a custom R
script that integrated the topological scores of every path-
way by sorting and intersecting the nodes with the higher
betweenness centrality. This produced a list of high centrality
nodes. Such nodes are promising regulators with a key role in
signaling cascades related to aging.
D. Finalization
High centrality nodes identified in the previous step were
finally mapped to a global network. The ReNE Cytoscape
plugin was used to merge all the analyzed pathways and
the initial list of differentially expressed genes. The merging
process produced a large network that was filtered in order
to retain only the high centrality nodes thus reducing its
complexity. This filtered subnetwork is a good candidate to
highlight the most important inter-pathways regulatory entities,
defined accordingly to their high centrality.
III. RESULTS AND DISCUSSION
A set of 191 differentially expressed genes out of 8,799
available microarray data were identified using the GEO
Differential Expression filter on the GSE421 Dataset. The
list was further reduced removing non-genes references (see
Section II-A) obtaining a list 177 candidate differentially
expressed genes in heart aging. By performing naming normal-
ization using ReNE the list of 177 genes was further reduced to
157 human homologs with a valid NCBI ID2. KEGG pathways
were ranked according to these 157 genes (see Section II-A)
and the 15 top ranked pathways were manually analyzed
selecting the following 7 relevant pathways:
• MAPK (hsa04010): MAP kinases are involved in many
different cellular functions like apoptosis, prolifera-
tion, survival, growth arrest, differentiation, motility,
metabolism and senescence. Alterations in the MAPK
signaling pathway have been reported in several tissues
during aging [26].
• Rap1 (hsa04015): promotes integrin and cadherin sig-
naling and is activated by shear stress to regulate NO
production in endothelial cells. Rap1 deficiency in murine
endothelium leads to endothelial dysfunction and hyper-
tension, common diseases in the elderly [27].
• Neuroactive ligand-receptor interaction (hsa04080): car-
diovascular diseases and aging are both associated with
changes in the neurohumoral system, mainly adrenergic
and renin-angiotensin systems. In particular, it has been
reported a decrease in catecholamine-responsiveness in
the elderly [28] and its regulatory effect in pathways
disturbed in heart failure [29].
• cAMP (hsa04024): is a secondary messenger generated by
adenylate cyclase, downstream to β-adrenergic signaling.
Genetic inhibition of cAMP signaling in the mouse my-
ocardium protects against heart failure, attenuates heart
aging and prolongs lifespan (interestingly, in the heart of
these mice, the Raf1/MEK/ERK and the AKT pathways
are activated) [30].
• PI3K-Akt (hsa04151): controls a multitude of biologi-
cal processes in myocardial cells, e.g., cardiomyocyte
hypertrophy, survival, energy production, contractility,
and response to stress. Some evidences indicate that
attenuation of the PI3K/AKT pathway contributes to age
related changes in myocardium [31].
• Alzheimer’s disease and Huntington’s disease (hsa05010,
hsa05016): protein misfolding plays a crucial role in
neurodegenerative diseases. Increasing evidences indicate
that, in the myocardium, mechanical and oxidative stress
together with other pathological conditions lead to protein
misfolding and that misfolded proteins play a relevant
role in the onset and progression of cardiomyopathies
[32]. Recently, extensive links have been identified be-
tween Alzheimer’s disease and cardiovascular diseases in
large-scale genome-wide association studies [33].
The 7 selected pathways and the list of 157 genes were
processed using ReNE as described in Section II-B. As a
result, 3 new TF nodes and 7 miRNA nodes were globally
inserted. Moreover, as a result of this process, the list of 157
differentially expressed genes was connected and transformed
into a new pathway thus obtaining a list of 8 processed
pathways qualitatively depicted in Fig. III-A. The 8 processed
networks were analyzed using the Cytoscape NetworkAna-
lyzer as described in Section II-C to compute betweenness
2The following entities have been discarded: Gstm7, LOC687048,
LOC100365443, LOC100363469, LOC688869, Reg3b, LOC100364956,
LOC100360403, Ly6al, LOC290595, Olr1642, RT1-M4, LOC100362894,
Kng1l1
centrality of each node. Results from all pathways were
merged to sort genes based on their betweenness centrality and
the top 40 nodes were selected as high centrality nodes, i.e.,
nodes with high likelihood of having a key role in signaling
cascades related to aging. Malfunctions in these nodes will
easily lead to widespread functional misbehavior of the entire
regulatory network.
The 8 pathways were then merged obtaining a very large
network qualitatively reported in Fig. III-B. The network
complexity was reduced by collapsing protein nodes into their
related coding genes (protein information are only required
by ReNE for intermediate processing) obtaining a network
composed of 909 nodes (i.e., genes, TFs, and, miRNAs) and
6,475 edges. By filtering this complex network with the set
of identified high centrality nodes we were able to extract a
sub-network containing 35 interconnected nodes qualitatively
depicted in Fig. III-C. A detailed view of the network depicting
the 35 identified regulators and their interactions is reported
in Fig. 3. This network represents a candidate inter-pathway
regulatory model of senescence related signal cascades.
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Figure 2. Conceptual processing steps. A – Seven KEGG pathways (hsa0401, hsa04015,
hsa04024, hsa04080, hsa04151, hsa05010 and hsa05016), and a list of 157 differentially
expressed genes (extracted from GEO) were processed using ReNE to add transcriptional
and post-transcriptional regulators (green nodes: miRNAs, dark blue nodes: TFs, red
nodes: proteins). B – the processed pathways were merged resulting in a large merged
network. C – after centrality analysis genes with highest betweenness centrality were
extracted along with their regulatory links, resulting in a small filtered network.
Literature validation confirmed that the nodes of the filtered
subnetwork have been reported in different studies on heart
aging response. The role of the identified genes, miRNAs
and TFs was mapped, for the sake of clarity, against six
main functional classes: 1) inflammatory response, 2) senes-
cence regulation, 3) beta-adrenergic signaling, 4) MAP2K and
ERK1/2 signaling pathways, 5) miRNAs, and 6) TFs. Five
out of the seven identified miRNAs and all three identified
TFs were reported as involved in senescence or inflammatory
processes. Their role is of particular interest because they can
finely tune the network behavior shading new light into the
complex regulatory mechanisms underlying senescence. Over-
all, 32 out of the 35 network nodes (94%) have been previously
reported in studies on aging related processes. The two missing
nodes, i.e., miR-4691and miR-7113, represent two interesting
candidates for future investigations. In particular, miR-4691
with his role of regulatory hub with 9 regulated nodes is a
particularly interesting node to be investigated in laboratory.
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Figure 3. The resulting heart aging model. Nodes are colored to highlight their different
roles: in purple Beta-Adrenergic signaling related nodes, inflammatory response in red,
MAPK-Erk1/2 in yellow, senescence regulation in pale violet, microRNAs in green, and,
transcription factors in blue. Edges are colored according to the following criteria: red
for miRNA post-transcriptional repression, green for miRNAs co-transcription with their
host gene, and black for regulations inherited from KEGG’s pathways.
A. Inflammatory Response related genes
NDUFS8: mitochondria are necessary for the pro-
inflammatory and pro-oxidant features of senescent phenotype.
Their biogenesis stabilizes senescence via a crosstalk with the
ATM, Akt, and mTOR signaling pathways. Since the increased
mitochondrial mass is invariably reduced by rapamycin the
mTOR pathway has a central role in mitochondrial regulation.
mTOR inhibition results in a down expression of mTOR
complex 1 (mTORC1), which integrates stress signals into the
regulation of protein and lipid synthesis and autophagy, all
of which are involved in the complex pathways mediating
mitochondrial homeostasis. In this context, NDUFS8 is a
mTORC1 downstream regulated gene and its presence may
be an hallmark of mitochondrial regulation [34].
EIF4A2: is a member of the helicase family. Helicases are
known as guardians of the genome given their role in various
DNA metabolic pathways that include DNA recombination,
replication, repair, transcription and telomere maintenance.
EIF4A2 seems related to aging by influencing protein transla-
tion and mitochondrial translocation efficiency [35].
ENO1: studies reported that ENO1 is an auto-antigen that
has been recognized as a common marker of systemic au-
toimmune diseases and inflammatory, degenerative and other
pathological disorders. It is induced by cellular stress and
promote cell growth, glycolysis, migration, and invasion [36].
CSF1R: the colony-stimulating-factor receptor-1 (CSF1R)
is a type III receptor tyrosine kinase primarily reported as
responsible for the proliferation, differentiation and survival
of the monocyte–macrophage cell lineage, as well as their
recruitment. Two ligands (CSF1 and IL34) function through
non-competitive binding to CSF1R by activating both phos-
phatidylinositol 3-kinase PI3K-dependent and RAS-activated
protein kinase-dependent pathways. Senescent cells also re-
vealed that AKT inhibition in CSFR-expressing cells is ac-
companied by the ectopic regulation of CDKN1A, SOX2,
OCT4 and c-MYC proteins. This establishes an interesting
link between the expression of CSF1R, AKT activation and
physical crosstalk between the PI3K, AKT, STAT3, and NFKB
pathways [37].
PLCB1: acts as catalyst for the formation of inositol 1,4,5-
trisphosphate and diacylglycerol from phosphatidylinositol
4,5-bisphosphate. This reaction plays an important role in the
intracellular transduction of many extracellular signals. PLCB1
has been identified as a pro-inflammatory regulator involved
in several cardiovascular diseases as acute, inflammatory,
and self-limited vasculitis, Kawasaki Syndrome, endothelial
cell inflammation with varying degrees of pro-inflammatory
cytokine expression, and coronary artery aneurysm. [38]
B. Senescence Regulation
PLEC: laminar shear stress (LSS) caused by blood flow is
known to regulate endothelial function and to contribute to
vascular health. However endothelial cell senescence seems to
increase the incidence of cardio vascular disorders. PLEC1 is
an actin binding protein induced in endothelial cells exposed to
LSS. Studies demonstrated that several actin binding proteins
including PLEC1 may play a critical regulatory role in the
endothelial wound healing under LSS conditions [39].
BRAF: constitutive activation of BRAF may drive the prolif-
eration and maturation/senescence of melanoblasts. In mature
human skin, descendant melanoblasts reside in the epidermis
but they colonize all the tissues of the body, such as the valves
of the heart and the meninges [40].
GNAQ: its mutations have been associated with defects in
platelet activation and aggregation, and port-wine stains. It is
involved in estradiol-responsive pathway and produces age-
related differences in functional pathways related to oxidative
phosphorylation, synaptic plasticity, and estrogen responsive
signaling cascades. GNAQ has also been recently reported as
possibly responsible (with NRAS/BRAF-mutations) for tran-
scriptional modifications in uveal melanoma and blue nevi that
lead to melanoblast proliferation and melanocyte differentia-
tion [40].
CREB3: is a regulator known to physically associate with
the endomembrane system. It has been found ectopically
expressed in abnormal lysosomes with impaired function. Ab-
normalities of lysosomal functions are characteristic of cellular
senescence, organismal ageing, atherosclerosis, Alzheimer’s
and other diseases. Ectopic secretion of lysosomal proteases
can, in fact, degradate extracellular matrix, contributing to
atherosclerosis, arthritis, aneurysms formation, and other dis-
eases [41].
MYH6: myosin-6 has been demonstrated ectopically regu-
lated in senescent rats against young rats [42].
FAS: is a TNF receptor, shown to activate NFKB,
MAPK3/ERK1, and MAPK8/JNK pathways. It is involved
in transducing the proliferating signals in normal diploid
fibroblast and T-cells. FAS appears impaired in senescence-
associated secretory phenotype (SASP) proteases, i.e., cleave
FAS ligand and other cell surface proteins required for effective
immune function. The macrophage responses result declining
with aging, potentially contributing to senescent cell accumu-
lation in old age, which eventually results in a reduced immune
function [43].
ADCY1: encodes a member of the of adenylate cyclase gene
family. ADCY1 has been identified as functionally responsible
for enhanced forskolin-stimulated association with ERK that
eventually contributes to cAMP elevation in vascular smooth
muscle cells. cAMP over expression in the plasma membrane
intensely strengthen the endothelial barrier function, resulting
in cardiac rejuvenation, and suggests possibly regenerative
potential in aged tissues. ADCY1 ectopic activity is also proven
sufficient to overwhelm the barrier protective effects of plasma
membrane activity to promote endothelial gap formation [44].
CHUK: encodes a member of the serine/threonine protein
kinase family. The encoded protein is an inhibitor of the tran-
scription factor NFKB complex. In aging, reduced inhibition
of NFKB is associated with the pro-inflammatory phenotype
in vascular endothelium [45].
C. Beta-Adrenergic signaling
Chronic activation of beta-adrenergic signaling is delete-
rious to cardiac function resulting in increased heart rate,
contractility, peripheral vasoconstriction and wall stress. Stim-
ulation of beta-adrenergic receptors decreases anti-apoptotic
and anti-oxidative stress signaling contributing to senescence
and functional deterioration in a cascading effect with down-
stream induction of cAMP and PKA that act as inhibitors of
the cardioprotective Raf/MEK/Erk pathways. In aging human
heart, the functional responsiveness of the human cardiac
beta-adrenoceptor system decreases along with all the effects
mediated by cAMP.
PTOV1: androgens have been considered to reduce the in-
cidence of ischemic myocardial disease in men, but they have
also been reported to exert atherogenic effects on the human
cardiovascular system through promoting plaque formation
and enhancing monocyte adhesion to endothelial cells. In this
context, PTOV1 is considered to be one of the testosterone-
induced genes involved in androgen-mediated stimulation of
VSMC proliferation. PTOV1 may thus play an important role in
androgen-related atherogenesis in the male human aorta [46].
TECR: is a poorly characterized testosterone reduction en-
zyme member of steroid 5-alpha reductase family, which also
contains SRD5A2L2, SRD5A1, SRD5A2, SRD5A3. SRD5A1
and SRD5A2 have been already identified as encoders for
proteins targeted in treatments against prostate cancer and
male pattern hair loss (male aging related diseases). However
the role of TECR is still not clear. It has been shown to be
involved in the elongation of very long chain fatty acids and
reduction of a non-steroid lipid. NbECR, a TECR homolog in
Nicotiana Benthamiana, has been identified as responsible for
disorganized membrane structures and epidermal cell ablation.
Those assumptions make TECR a candidate as processor for
adrenergic and hormonal signals, capable to possibly lead to
vascular membranes impairment [47], [48].
C00575 (cAMP): cAMP is a second messenger used for
intracellular signal transduction such as transferring into cells
the effects of hormones like glucagon and adrenaline, which
cannot pass through the plasma membrane. cAMP also reg-
ulates the function of ion channels and a few other cyclic
nucleotide-binding proteins such as RAPGEF3. Exchange pro-
teins activated by cAMP (RAPGEFx), when cAMP binds,
expose the activated GEF domain, allowing them to activate
small Ras-like GTPase, such as RAP1 [49].
RAP1: a GTPase superfamily member highly involved in
cell motility and junction formation. It acts as a substrate
for protein kinase A and interacts with NADPH oxidase (a
group of multimeric enzymes whose activity results in the
production of O2). In non-phagocytic cells, homologues of the
NADPH oxidase were found in vascular endothelial cells and
smooth muscle cells or transformed cells such as melanoma.
Activation of RAP1 strengthens cell junction integrity and
reduces cell migration by affecting actin cytoskeleton remod-
eling [50]. RAP1 also acts as a protective protein for telomeres
by relocalizing to the upstream promoter regions of hundreds
of new target genes when critical telomere shortening happens.
RAP1 role in delaying senescence and concurring in DNA
damage responses makes it (and its surrounding regulators) a
good candidate for actively managing senescence [51].
D. MAP2K and ERK1/2 signaling pathways
Activation of β-adrenergic receptors results in the produc-
tion of cyclic AMP which in turn phosphorylates many tran-
scriptional factors via the MAPK pathway and thus, stimulates
protein synthesis and cell growth. In the filtered network, we
identified a central cluster of genes that recurs in several
high relevance pathways: Ras, Raf, MAP2K, and, ERK1/2
signaling pathways. Such pathways are also highly intercon-
nected to each other showing a concurrent role in crucial cell-
survival regulations. At the cellular level, the ERK1/2 pathway
regulates cell cycle progression, proliferation, cytokinesis,
transcription, differentiation, senescence, cell death, migration,
GAP junctions formation, actin and microtubule networks, and
cell adhesion. MAPK pathway plays a role in many biological
functions like cell cycle regulation, apoptosis, cell survival,
senescence, differentiation, and cell growth and migration.
RRAS2: encodes a small GTPase involved in diverse
processes including angiogenesis, vascular homeostasis and
regeneration, and cell adhesion. RAS proteins interact with
multiple effectors, including RAF kinases, PI-3 kinases, and
activate multiple downstream signaling cascades. Of particular
interest the RAS/mitogen-activated protein kinase RAS/MAPK
signaling pathway, which plays a central role in cellular
proliferation and differentiation. RRAS2 also plays a key
role in Noonan syndrome, an autosomal-dominant disorder
characterized by congenital heart defects. [52]
ST8SIA4: is predominantly expressed in immune cells. It
plays an important role in substrate recognition that modulates
cell adhesion and signaling. Furthermore, ST8SIA4 mediates
the activity of PI3K/Akt signal pathway in a competitive way.
Inhibition of PI3K/Akt pathway is also able to attenuate the
effects caused by the overexpression of ST8SIA4 on MDR [53].
RAPGEF3: is necessary for antioxidant and antiapoptotic
effects of exendin, which has an essential role in cardiomy-
ocytes and is involved in the development of heart failure.
RAPGEF3 also drives the inhibitions of oxidative stress and
apoptosis in cardiomyocytes thanks to GLP-1R which helps in
cardioprotection, and also inactivates myosin light chain kinase
[54]. Elevated levels of cAMP activate RAPGEF3 which, in
turn, leads to GTP binding to Rap1. This causes changes to the
cortical cytoskeleton and organization of vascular endothelial
cadherin in the endothelial junctions, leading to reduced en-
dothelial permeability. Ectopic expression of RAPGEF3 may
thus result in cell aging effect [55].
RAF1: its activation engages the phosphorylation cascade
starting from RAF1 (MKKK) to MAP2K, and then to the
MAPK family. RAF1 was found to be an activator of MAP2K
in mammalian cells and to form a stable complex with
MAP2K. Prototypically, growth factors activate RAS which
recruits and activates RAF at the plasma membrane. Once
activated, RAF phosphorylates and activates MAP2K, which
in turn activates ERK1/2. Eventually activated ERK1/2 can
phosphorylate downstream proteins in the cytoplasm or nu-
cleus, including many transcription factors. Cardiac specific
deletion of RAF1 leads to heart failure without hypertrophy
in the absence of external stress, and also increases apoptosis
[56].
PIK3R5: activates the Ras-Raf-MAP2K-ERK signalling cas-
cade. PI3K also represents a downstream target of active
RAS. Suppression of PI3K prevents lipofuscin accumulation
in aged heart tissue. Lipofuscin is thought to be generated
from damaged proteins and post mitotic cells (such as cardiac
myocytes) accumulate a large amount of lipofuscin in old
age. Inhibition of PI3K, in fact, prevents the expression of
cellular senescence markers (by decreasing the accumulation
of lipofuscin in heart tissue) and most of the age-related
changes of gene expression [57], [58].
MAPK1/MAP2K3/MAP2K1: the MAPK cascade is com-
posed of RAS, RAF1, MAP2K, MAPK1 and RSK. It spans
from the plasma membrane to the nucleus and trasduces
the mitogenic signals downstream from the tyrosine kinase
membrane receptor. The first subgroup of MAPK (ERK1/2)
plays an important role in the signaling pathway responsible
for the G0 to G1 transition in the cell cycle. The MAPK1
pathway is coupled by a GTP-binding protein (Gαq-protein
isoform in the heart) that activates the ERK1/2 pathway.
The activation of the ERK1/2 pathway in heart is lead by
a GTP-binding protein (Gαq-protein isoform) that produces
diacylglycerol (DAG) and inositol-3,4,5-triphosphate (InsP3).
DAG then activates the MAPK1 signaling cascade, while
InsP3 activates the MAPK1 pathway via both RAS-dependent
and -independent mechanisms. The activity of MAPK1 is
stimulated by multiple extracellular stimuli and oncogenes.
Its activation regulates several cellular protein kinases, and
catalyzes the phosphorylation of some nuclear transcription
factors [58]. Finally, mutations in HRAS, KRAS, BRAF, and
MAP2K have also been discovered to be involved in other
genetic disorders with cardiac developmental defects, such as
LEOPARD syndrome, cardio-facio-cutaneous syndrome, and
Costello syndrome [56].
E. MicroRNA
MiRNAs are key regulators of gene expression. By binding
to multiple genes at once, they create a complex network of
post-transcriptional fine co-regulations.
miR-6728: has been demonstrated to be able to regulate sev-
eral genes associated with cardiometabolic phenotypes [59].
miR-639: recently emerged as potential novel biomarker of
Human bone marrow mesenchymal stem cells aging [60].
miR-661: has been demonstrated to have a regulatory role
in small GTPase signalling. It also has an active role in phos-
phorylation of myosin II and up regulates the cell invasion,
indicating a possible oncogenic miRNA [61]. miR-661 is also
highly associated with nano-sized vesicles released by acti-
vated CD4+ T lymphocytes release [62] showing a correlation
with inflammatory response, and with the modulation of the
endogenous levels of iNOS and nitrite production via MTA1
mediated control. [63]
miR-1248: studies investigating the relationships between
miRNA profiles and aging reported that serum expression
levels of miR-1248 were significantly lower in old participants
(mean age, 64 years) than in young participants (mean age,
30 years). miR-1248 was found to regulate the expression of
mRNAs related to several cytokines (age-associated cytokines
IL6 and IL8) and inflammatory-associated pathways (including
NF-kB), thus suggesting a relevant role in the aging process.
miR-1248 also influences the impaired DNA repair capacity,
then decreased levels of miR-1248 due to aging directly affect
DNA repair pathways [64].
miR-208a: targets thyroid hormone receptor associated pro-
tein 1 (THRAP1) and myostatin, which are negative regulators
of muscle growth and hypertrophy. It is particularly relevant
in cardiac myocytes, since its transgenic overexpression in
the heart is sufficient to induce hypertrophic growth and
arrhythmias in mice. miR-208a also has a key role in the
expression of cardiac transcription factors, like homeodomain-
only protein (HOP) and GATA4, and for the gap junction
protein connexin. Upregulation of miR-208a was observed in
samples of infarcted heart tissue from patients with myocardial
infarction compared to healthy adult hearts. Given its high
sensitivity in early setting of acute myocardial infarction
(AMI), miR-208a seems a reliable biomarker for early AMI
diagnosis in humans [65]
F. Transcription Factors
TP53: TP53 encodes a tumor suppressor protein, whose
expression is stabilized by DNA damage. In order to suppress
tumor development, TP53 has a key role in leading to senes-
cence as mechanism to prevent tumor formation and to have a
trade-off relation with cancer. Overexpression of TP53, in fact,
induces cell cycle arrest, apoptosis, senescence, DNA repair,
or changes in metabolism [36].
NFKB1: is a binding subunit of the NFKB protein complex,
a transcription regulator that acts as hub by aggregating mul-
tiple intra- and extra-cellular stimuli (i.e., cytokines, oxidant-
free radicals, ultraviolet irradiation, pathogens). Ectopic activa-
tion of NFKB has been associated with inflammatory diseases
and inappropriate immune cell development or delayed cell
growth. In particular, the NFKB1 subunit is known to be
responsible for proinflammatory arterial phenotype developed
with aging, and is associated to vascular dysfunctions due to
impaired nitric oxide processing [66].
MYC: is a multi-functional, nuclear phosphoprotein that
plays a role in cell cycle progression, apoptosis and cellular
transformation. MYC is necessary and sufficient for the regu-
lation of Nucleostemin (NS) (a nucleolar protein regulating
stem cell proliferation and pluripotency). NS regulation is
essential to preserve the regenerative potential of aging stem
cells by antagonizing senescence and by enhancing myocardial
regeneration. Levels of MYC, positive transcriptional regula-
tors of the cell cycle, are decreased in myocardial senescence
along with elevated levels of TP53, which eventually result
in enlarged myocytes, reduced number of cardiomyocytes,
disfigured mitochondrial morphology, telomere attrition, up-
regulation of molecular markers of senescence, and decline in
cardiac function resembling a heart failure phenotype [67].
IV. CONCLUSIONS
This paper presented a pure computationally inferred model
that is able to represent the relationship between key genes
and miRNAs involved in cardiac senescence processes. Inter-
estingly, all the newly introduced regulators, except for two
miRNAs (i.e., miR-4691 and miR-7133), appear strongly re-
lated to previous studies on aging related mechanisms. Giving
the results obtained on the other regulators, these two miRNAs
represent good candidate for further studies to elucidate their
possible involvement in cardiac aging. On-going work is now
focusing on laboratory experiments to validate some of the
most promising interactions identified in the model.
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